Latest News

Pioneering medical device company focused on innovative solutions for cerebral venous diseases

Sonorous NV, Inc. Announces Leadership Transition

Sonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT™

To report the clinical and imaging outcomes of the BosSTENT™, a novel self-expanding braided stent, in patients with symptomatic TSS.

Sonorous Neurovascular Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort

Novel, braided, self-expandable stent designed for the treatment of pulsatile tinnitus caused by intracranial venous stenosis: first-in-human experience and long-term outcomes

Sonorous NV Uses New Device to Treat Patients with Symptomatic Cerebral Venous Diseases